Surrozen (SRZN) Non Operating Income (2020 - 2021)

Surrozen (SRZN) posted quarterly Non Operating Income of -$328000.0 for Q3 2021, up 87.06% quarter-over-quarter from -$2.5 million in Q2 2021.

Surrozen (SRZN) Non Operating Income (2020 - 2021) Analysis & Trends

Surrozen's Non Operating Income history runs 2 years deep, the most recent figure standing at -$328000.0 for Q3 2021.

In Q3 2021, Non Operating Income changed N/A year-over-year to -$328000.0; the TTM figure through Sep 2021 stood at -$3.7 million (changed N/A YoY), while the FY2020 annual figure was -$1.7 million, changed N/A from the prior year.
Non Operating Income for Q3 2021 stood at -$328000.0, up from -$2.5 million in the prior quarter.
The five-year high for Non Operating Income was $832245.0 in Q1 2021, with the low at -$2.5 million in Q2 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non Op. Inc. (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	234.30 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-139.24 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	12.40
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-51.63 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-53.64 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Surrozen	281.63 Mn	281.63 Mn	-	-

Download Data